EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial

G Justus Hofmeyr, Mandisa Singata-Madliki, Joanne Batting, Petrus Steyn, Katherine K Thomas, Rodal Issema, Ivana Beesham iD, Enough Mbatsane, Charles Morrison, Jen Deese, Jenni Smit, Neena Philip iD und 6 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0299802 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von G Justus Hofmeyr und 17 weiteren Autor:innen. Beteiligte Einrichtung: University of Botswana, Gaborone, Botswana. Hauptthemen laut MEDLINE: Levonorgestrel, Medroxyprogesterone Acetate, Intrauterine Devices, Copper, Sexual Behavior. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Bill and Melinda Gates Foundation, United States Agency for International Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Contraceptive use has complex effects on sexual behaviour and mood, including those related to reduced concerns about unintended pregnancy, direct hormonal effects and effects on endogenous sex hormones. We set out to obtain robust evidence on the relative effects of three contraceptive methods on sex behaviours, which is important for guiding contraceptive choice and future contraceptive developments.

Methods

This is a secondary analysis of data from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) randomized trial in which 7,829 HIV-uninfected women from 12 sites in Eswatini, Kenya, South Africa and Zambia seeking contraception were randomly assigned to intramuscular depot-medroxyprogesterone acetate (DMPA-IM), the copper intrauterine device (Cu-IUD) or the levonorgestrel (LNG) implant. Data collected for 12 to 18 months using 3-monthly behavioural questionnaires that relied on recall from the preceding 3 months, were used to estimate relative risk of post-baseline sex behaviours, as well as sexual desire and menstrual bleeding between randomized groups using modified Poisson regression.

Results

We observed small but generally consistent effects wherein DMPA-IM users reported lower prevalence of specified high risk sexual behaviours than implant users than Cu-IUD users (the ‘>‘ and ‘0.5%; amenorrhoea by 49% > 41% >12% and regular menstrual pattern by 26%

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevonorgestrelMedroxyprogesterone AcetateIntrauterine Devices, CopperSexual BehaviorHumansFemaleAdultYoung AdultContraceptive Agents, FemaleAdolescentInjections, IntramuscularContraceptionDrug Implants

Substanzen

LevonorgestrelMedroxyprogesterone AcetateContraceptive Agents, FemaleDrug Implants

Autor:innen und Institutionen

  • University of Botswana, Gaborone, Botswana.
  • Effective Care Research Unit, University of the Witwatersrand/Walter Sisulu University, East London, South Africa.
  • Effective Care Research Unit, University of Witwatersrand, University of Fort Hare, East London, South Africa.
  • UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Geneva, Switzerland.
  • Department of Global Health, University of Washington, Seattle, Washington, United States of America.
  • Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.

ORCID-Profile: Ivana Beesham, Neena Philip, Thesla Palanee-Phillips

Förderung

  • World Health Organization
  • Bill and Melinda Gates Foundation
  • United States Agency for International Development
  • Styrelsen för Internationellt Utvecklingssamarbete
  • South African Medical Research Council
  • United Nations Population Fund
  • National Department of Health

Zitieren

APA

Hofmeyr, G. J., Singata-Madliki, M., Batting, J., Steyn, P., Thomas, K. K., Issema, R., Beesham, I., Mbatsane, E., Morrison, C., Deese, J., Smit, J., Philip, N., Palanee-Phillips, T., Reddy, K., Onono, M., Mastro, T. D., Baeten, J. M., & Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium (2024). Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0299802

Vancouver

Hofmeyr GJ, Singata-Madliki M, Batting J, Steyn P, Thomas KK, Issema R, et al. Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. PLOS ONE. 2024. doi:10.1371/journal.pone.0299802

BibTeX
@article{Hofmeyr2024,
  author = {Hofmeyr, G Justus and Singata-Madliki, Mandisa and Batting, Joanne and Steyn, Petrus and Thomas, Katherine K and Issema, Rodal and Beesham, Ivana and Mbatsane, Enough and Morrison, Charles and Deese, Jen and Smit, Jenni and Philip, Neena and Palanee-Phillips, Thesla and Reddy, Krishnaveni and Onono, Maricianah and Mastro, Timothy D and Baeten, Jared M and Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium},
  title = {Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0299802}
}
Kostenlos starten →